🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Theodore Larson

Agency for Toxic Substances and Disease Registry

ORCID: 0000-0003-4719-4829
MedicineEnvironmental Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile
4.0Author DataRank

Indexed papers

4in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 4 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Prevalence of amyotrophic lateral sclerosis in the United States using established and novel methodologies, 2017

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration(2022)10.1080/21678421.2022.2059380
Top 7%
3.4DataRank
Top 7%76 citations

Jaime Raymond, Reshma Punjani, Moon Han, Theodore Larson, Wendy Kaye +6 more

Papers

Driven by 7 papers — median percentile 47. Top paper: “Prevalence of amyotrophic lateral sclerosis in the United States using established and novel methodologies, 2017”.

Prevalence of amyotrophic lateral sclerosis in the United States using established and novel methodologies, 2017

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration(2022)10.1080/21678421.2022.2059380
Top 7%
3.4DataRank
Top 7%76 citations

Jaime Raymond, Reshma Punjani, Moon Han, Theodore Larson, Wendy Kaye +6 more

Recruitment of population-based controls for ALS cases from the National ALS Registry

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration(2021)10.1080/21678421.2021.1887262
Top 50%
0.348DataRank
Top 50%4 citations

Angela M. Malek, Abigail Foulds, Judith R. Rager, Sarah DePerrior, John E. Vena +5 more

A brief report on juvenile amyotrophic lateral sclerosis cases in the United States National ALS Registry: 2010–2018

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration(2023)10.1080/21678421.2023.2264922
Top 56%
0.293DataRank
Top 56%4 citations

J.L. Berry, Edward J. Kasarskis, Theodore Larson, D. Kevin Horton, Paul Mehta +1 more

What do you think caused your ALS? An analysis of the CDC national amyotrophic lateral sclerosis patient registry qualitative risk factor data using artificial intelligence and qualitative methodology

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration(2024)10.1080/21678421.2024.2349920
N/A
0DataRank · unranked
7 citations

Jaime Raymond, Theodore Larson, Eddie Kirkland, D. Kevin Horton, Paul Mehta +1 more

Impact of the National Amyotrophic Lateral Sclerosis Registry: Analysis of Registry‐funded Research

Annals of Clinical and Translational Neurology(2022)10.1002/acn3.51660
N/A
0DataRank · unranked
5 citations

Stephan Brenner, Marcienne M. Wright, Maggie Ritsick, Farhana Rahman, Moon Han +5 more

Response to ‘Follow-Up of the Libby, Montana Screening Cohort

Journal of Occupational and Environmental Medicine(2020)10.1097/jom.0000000000001837
N/A
0DataRank · unranked
1 citations

Laura Williamson, Vinicius C. Antao, Theodore Larson

Comparing Amyotrophic lateral sclerosis (ALS) patient characteristics from the National ALS Registry and the Massachusetts ALS Registry, data through 2015

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration(2023)10.1080/21678421.2023.2239301
Top 100%
0DataRank
Top 100%0 citations

Reshma Punjani, Theodore Larson, James D. Berry, D. Kevin Horton, Paul Mehta +1 more